FNGD vs. LABD
Compare and contrast key facts about MicroSectors FANG+™ Index -3X Inverse Leveraged ETN (FNGD) and Direxion Daily S&P Biotech Bear 3x Shares (LABD).
FNGD and LABD are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FNGD is a passively managed fund by BMO Financial Group that tracks the performance of the NYSE FANG+ Index (-300%). It was launched on Jan 22, 2018. LABD is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (-300%). It was launched on May 28, 2015. Both FNGD and LABD are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FNGD or LABD.
Performance
FNGD vs. LABD - Performance Comparison
Returns By Period
In the year-to-date period, FNGD achieves a -71.63% return, which is significantly lower than LABD's -27.72% return.
FNGD
-71.63%
-14.70%
-45.79%
-75.28%
-77.69%
N/A
LABD
-27.72%
19.96%
-11.31%
-61.67%
-53.26%
N/A
Key characteristics
FNGD | LABD | |
---|---|---|
Sharpe Ratio | -1.07 | -0.79 |
Sortino Ratio | -2.26 | -1.16 |
Omega Ratio | 0.75 | 0.87 |
Calmar Ratio | -0.76 | -0.63 |
Martin Ratio | -1.37 | -1.06 |
Ulcer Index | 55.79% | 59.52% |
Daily Std Dev | 71.40% | 79.50% |
Max Drawdown | -99.98% | -99.97% |
Current Drawdown | -99.98% | -99.96% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FNGD vs. LABD - Expense Ratio Comparison
FNGD has a 0.95% expense ratio, which is lower than LABD's 1.06% expense ratio.
Correlation
The correlation between FNGD and LABD is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
FNGD vs. LABD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MicroSectors FANG+™ Index -3X Inverse Leveraged ETN (FNGD) and Direxion Daily S&P Biotech Bear 3x Shares (LABD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FNGD vs. LABD - Dividend Comparison
FNGD has not paid dividends to shareholders, while LABD's dividend yield for the trailing twelve months is around 4.39%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
MicroSectors FANG+™ Index -3X Inverse Leveraged ETN | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Direxion Daily S&P Biotech Bear 3x Shares | 4.39% | 6.14% | 0.53% | 0.00% | 3.96% | 1.75% | 0.80% |
Drawdowns
FNGD vs. LABD - Drawdown Comparison
The maximum FNGD drawdown since its inception was -99.98%, roughly equal to the maximum LABD drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for FNGD and LABD. For additional features, visit the drawdowns tool.
Volatility
FNGD vs. LABD - Volatility Comparison
The current volatility for MicroSectors FANG+™ Index -3X Inverse Leveraged ETN (FNGD) is 20.08%, while Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a volatility of 23.90%. This indicates that FNGD experiences smaller price fluctuations and is considered to be less risky than LABD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.